Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,346 | -10,267 | -7,262 | -2,265 | -10,256 |
| Depreciation Amortization | 81 | 65 | 46 | 87 | 139 |
| Other Working Capital | 673 | 378 | 837 | -373 | -679 |
| Other Operating Activity | 4,534 | 3,369 | 2,369 | 417 | 3,534 |
| Operating Cash Flow | $-9,058 | $-6,455 | $-4,010 | $-2,134 | $-7,262 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -2 | -2 | N/A | -239 |
| Investing Cash Flow | $-2 | $-2 | $-2 | $N/A | $-239 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -205 | -155 | -93 | -32 | -184 |
| Common Stock Issued | 16,722 | 16,722 | 2,948 | 873 | 9,900 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 278 |
| Financing Cash Flow | $16,517 | $16,567 | $2,855 | $841 | $9,994 |
| Beginning Cash Position | 2,921 | 2,921 | 2,921 | 2,921 | 429 |
| End Cash Position | 10,378 | 13,032 | 1,764 | 1,628 | 2,921 |
| Net Cash Flow | $7,457 | $10,111 | $-1,157 | $-1,293 | $2,493 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,058 | -6,455 | -4,010 | -2,134 | -7,262 |
| Capital Expenditure | -2 | -2 | -2 | N/A | -239 |
| Free Cash Flow | -9,060 | -6,456 | -4,012 | -2,134 | -7,501 |